Search results for "Cirrhosis"
Electronic alert about lactulose linked to lower readmissions in patients with cirrhosis
The alert, which encouraged clinicians to prescribe rifaximin for patients with cirrhosis and hepatic encephalopathy who were on lactulose, increased uptake of rifaximin in such patients.
https://gastroenterology.acponline.org/archives/2022/01/28/3.htm
28 Jan 2022
Biopsy-proven NAFLD associated with higher rates of MACE
Patients in a Swedish study whose nonalcoholic fatty liver disease (NAFLD) was confirmed on biopsy were more likely to experience incident major adverse cardiovascular events (MACE).
https://gastroenterology.acponline.org/archives/2021/09/24/2.htm
24 Sep 2021
Spotlight on alcohol use and health outcomes
One recent study estimated that 1 in 8 deaths among U.S. adults ages 20 to 64 years is due to excessive alcohol consumption, while others examined all-cause and liver-related mortality in excessive drinkers and cardiovascular outcomes in patients with alcohol-related liver disease.
https://gastroenterology.acponline.org/archives/2022/11/18/5.htm
18 Nov 2022
Practice guidance addresses vascular liver disorders, portal vein thrombosis, procedural bleeding
Among other statements, the American Association for the Study of Liver Diseases said that modifiable risk factors for bleeding, such as use of antithrombotic drugs, should be identified and corrected before procedures in patients with cirrhosis.
https://gastroenterology.acponline.org/archives/2020/12/18/2.htm
18 Dec 2020
MKSAP Quiz: Dyspnea in a patient with liver disease
A 48-year-old woman with cirrhosis due to primary biliary cholangitis reports shortness of breath of six weeks' duration. Her oxygen saturation is 98% while supine, but it drops to 92% with standing. What is the most appropriate diagnostic test?
https://gastroenterology.acponline.org/archives/2021/05/28/5.htm
28 May 2021
Guideline offers recommendations on anticoagulation, thromboses in vascular liver disorders
Among other guidance, the American College of Gastroenterology recommends anticoagulation for all patients without cirrhosis who have acute symptomatic portal vein thrombosis or mesenteric vein thrombosis in the absence of any contraindication.
https://gastroenterology.acponline.org/archives/2020/01/24/1.htm
24 Jan 2020
Antibiotic may prevent hepatic encephalopathy after TIPS in patients with cirrhosis
A French trial found that 34% of patients who received rifaximin before and after placement of a transjugular intrahepatic portosystemic shunt (TIPS) had hepatic encephalopathy versus 53% of those who received placebo, with no differences in adverse events or transplant-free survival.
https://gastroenterology.acponline.org/archives/2021/02/26/7.htm
26 Feb 2021
Spotlight on mortality trends in liver disease
One study looked at 10-year U.S. mortality trends related to chronic liver diseases, while another assessed mortality from cirrhosis and liver cancer in the U.S. from 1999 to 2016.
https://gastroenterology.acponline.org/archives/2018/07/27/5.htm
27 Jul 2018
Rates of HDV co-infection may be higher than previously estimated
Patients with chronic hepatitis B virus (HBV) and hepatitis D virus (HDV) co-infection have the most severe form of viral hepatitis and are at much higher risk for cirrhosis and hepatocellular cancer than patients with HBV infection alone.
https://gastroenterology.acponline.org/archives/2018/09/28/3.htm
28 Sep 2018
Spotlight on direct-acting antivirals
Studies of contemporary populations with hepatitis C virus infection demonstrated that treatment with direct-acting antiviral therapies was linked to improvement in several long-term clinical outcomes.
https://gastroenterology.acponline.org/archives/2019/02/22/5.htm
22 Feb 2019